Wei Lin
- SEC CIK
- 0001872772
In the past year, 1 open-market sale filing worth $206.2K and no purchases.
Current role at each company
- RVMD Revolution Medicines, Inc.Chief Medical Officeras of Mar 19, 2026
- TSVT 2seventy bio, Inc.Directoras of May 15, 2025
- ERAS Erasca, Inc.Chief Medical Officeras of Feb 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $206.2K
- 1 filing
- Net
- −$206.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wei Lin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RVMD Revolution Medicines, Inc.
Chief Medical Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 (view filing) | Mar 17 | 2 days | Wei LinChief Medical Officer | SSale | −2.07K | $99.48 | −$206.2K | −2.0%101.4K after | 10b5-1 |
| Sep 18, 2025 (view filing) | Sep 16 | 2 days | Wei LinChief Medical Officer | SSale | −2.16K | $45.82 | −$99.0K | −2.4%88.3K after | 10b5-1 |
| Jun 18, 2025 (view filing) | Jun 16 | 2 days | Wei LinChief Medical Officer | SSale | −2.17K | $39.83 | −$86.6K | −2.3%90.5K after | 10b5-1 |
| Jun 20, 2024 (view filing) | Jun 17 | 3 days | Wei LinChief Medical Officer | SSale | −5.59K | $37.39 | −$209.0K | −7.3%70.9K after |